Literature DB >> 17624763

Structure/function of human type 1 3beta-hydroxysteroid dehydrogenase: An intrasubunit disulfide bond in the Rossmann-fold domain and a Cys residue in the active site are critical for substrate and coenzyme utilization.

James L Thomas1, Robert Huether, Vance L Mack, Launa A Scaccia, Ryan C Stoner, William L Duax.   

Abstract

The human type 1 (placenta, breast tumors) and type 2 (gonads, adrenals) isoforms of 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD) are key enzymes in steroidogenic pathways leading to the production of all active steroid hormones. Kinetic analyses of purified 3beta-HSD1 show that the Michaelis-Menten constants (Km) for substrates and cofactor are decreased dramatically (three- to eight-fold) by the addition of beta-mercaptoethanol (BME), which suggest that a disulfide bond may be critical to ligand utilization. Western immunoblots and SDS-PAGE of purified 3beta-HSD1 in the presence or absence of BME showed a lack of intersubunit disulfide bonds in the dimeric enzyme. The Rossmann-fold domain of 3beta-HSD1 contains two Cys residues, Cys72 and Cys111, which are capable of forming an intrasubunit disulfide bond based on their proximity in our structural model. Our structural model also predicts that Cys83 may affect the orientation of substrate and cofactor. To test these predictions, the C72S, C72F, C111S, C111A, C83S and C83A mutants of 3beta-HSD1 were produced, expressed, and purified. BME failed to diminish the Km values of substrate and cofactor for C72S, C72F, C111S and C111A but produced a 2.5 decrease in Km values for C83A ligands similar to wild-type 3beta-HSD. Thus, our results support the presence of an intrasubunit disulfide bond between Cys72 and Cys111 that participates in the tertiary structure of the Rossmann-fold domain. Although C83S had no enzyme activity, the C83A mutant enzyme exhibited two- to five-fold higher Km values for substrate and cofactor but had similar K(cat) values compared to wild-type 3beta-HSD. These data characterize the roles of Cys residues in 3beta-HSD and validate the predictions of our structural model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624763      PMCID: PMC2292410          DOI: 10.1016/j.jsbmb.2007.02.003

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  19 in total

1.  Human placental delta5-3beta hydroxysteroid dehydrogenase activity (delta5-3beta HSDH): intracellular distribution, kinetic properties, retroinhibition and influence of membrane delipidation.

Authors:  F Ferre; M Breuiller; L Cedard
Journal:  Steroids       Date:  1975-11       Impact factor: 2.668

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase: purification from microsomes, substrate kinetics, and inhibition by product steroids.

Authors:  J L Thomas; E A Berko; A Faustino; R P Myers; R C Strickler
Journal:  J Steroid Biochem       Date:  1988-11       Impact factor: 4.292

4.  Rational proteomics V: structure-based mutagenesis has revealed key residues responsible for substrate recognition and catalysis by the dehydrogenase and isomerase activities in human 3beta-hydroxysteroid dehydrogenase/isomerase type 1.

Authors:  Vladimir Z Pletnev; James L Thomas; Felicia L Rhaney; Lynley S Holt; Launa A Scaccia; Timothy C Umland; William L Duax
Journal:  J Steroid Biochem Mol Biol       Date:  2006-08-04       Impact factor: 4.292

5.  Kinetic studies of the applicability of the common site concept to the 3 beta-hydroxysteroid dehydrogenase: 5-ene-3-ketosteroid isomerase activities of human placental microsomes.

Authors:  C H Blomquist; C E Kotts; E Y Hakanson
Journal:  Steroids       Date:  1982-09       Impact factor: 2.668

Review 6.  Dissecting human adrenal androgen production.

Authors:  William E Rainey; Bruce R Carr; Hironobu Sasano; Takashi Suzuki; J Ian Mason
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

7.  Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase.

Authors:  James L Thomas; William L Duax; Anthony Addlagatta; Stacey Brandt; Robert R Fuller; Wendy Norris
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

8.  Crystal structure of human L-xylulose reductase holoenzyme: probing the role of Asn107 with site-directed mutagenesis.

Authors:  Ossama El-Kabbani; Shuhei Ishikura; Connie Darmanin; Vincenzo Carbone; Roland P-T Chung; Noriyuki Usami; Akira Hara
Journal:  Proteins       Date:  2004-05-15

9.  Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation.

Authors:  Rong Shi; Sheng-Xiang Lin
Journal:  J Biol Chem       Date:  2004-02-13       Impact factor: 5.157

10.  Substrate and nucleotide specificity of placental microsomal 3 beta-hydroxysteroid dehydrogenase.

Authors:  W Gibb
Journal:  Steroids       Date:  1981-01       Impact factor: 2.668

View more
  4 in total

1.  The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis.

Authors:  James L Thomas; Vance L Mack; Jingping Sun; J Ross Terrell; Kevin M Bucholtz
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-24       Impact factor: 4.292

Review 2.  Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.

Authors:  James L Thomas; Kevin M Bucholtz; Balint Kacsoh
Journal:  J Steroid Biochem Mol Biol       Date:  2010-08-22       Impact factor: 4.292

3.  Structural basis for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells.

Authors:  James L Thomas; Kevin M Bucholtz; Jingping Sun; Vance L Mack; Balint Kacsoh
Journal:  Mol Cell Endocrinol       Date:  2008-10-08       Impact factor: 4.102

4.  Structure/function of the inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane.

Authors:  James L Thomas; Vance L Mack; Jason A Glow; Delaram Moshkelani; J Ross Terrell; Kevin M Bucholtz
Journal:  J Steroid Biochem Mol Biol       Date:  2008-05-03       Impact factor: 4.292

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.